The Global Angioedema Treatment Market Growth Accelerated by Rising Prevalence of Angioedema Diseases

 Angioedema is a potentially life-threatening condition characterized by acute nonpitting edema of the deep dermis and subcutaneous tissues. It can occur either hereditary or acquired form. Angioedema treatment includes drugs such as C1 esterase inhibitors, bradykinin receptor antagonists, androgens, and antihistamines. 

The global angioedematreatment market is estimated to be valued at US$ 470.4 Mn in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
Rising prevalence of angioedema diseases is one of the major factors driving the growth of the angioedema treatment market. According to angioedema association, it is estimated that approximately 1 in 10,000 to 1 in 50,000 people suffer from hereditary angioedema in the United States. It usually begins appearing in teenagers and young adults and can be permanent if not treated. The increasing cases of angioedema diseases have raised the demand for effective treatment such as C1 esterase inhibitors and bradykinin receptor antagonists drugs. Also, growing awareness regarding various types of angioedema including hereditary, acquired, and idiopathic and their treatment options available in the market is further assisting the market growth.
Segment Analysis

The global angioedema treatment market is dominated by drug therapy segment. This is due to the high prevalence of angioedema conditions which can be treated using drugs. Within drug therapy, H1-antihistamines sub-segment holds the largest share as they are the first line of treatment for mild to moderate symptoms of angioedema. Corticosteroids sub-segment also has a significant share as they are used as adjuvant therapy along with H1-antihistamines for better management of symptoms.

Key Takeaways

The global angioedema treatment market is expected to witness high growth over the forecast period. North America currently dominates the market owing to increased awareness about the condition and availability of advanced treatment options in the region. However, Asia Pacific is expected to grow at the fastest pace due to rising healthcare expenditure, increasing patient population and presence of genericdrug manufacturers.

Regional analysis
North America is expected to maintain its leading position in the market during the forecast period. This is attributed to rising prevalence of hereditary angioedema in the US. However, Asia Pacific is projected to witness the highest growth rate owing to growing geriatric population, improving healthcare infrastructure and increasing focus of key players in emerging countries.

Key players
Key players operating in the angioedema treatment market are Bayer AG, Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co., Inc., Virbac S.A., Ceva Santé Animale, Elanco Animal Health, Bimeda, Aurobindo Pharma Limited, and Teva Pharmaceutical Industries Ltd.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more